Navigation Links
FDA Approves NovoLog(R) Labeling Update
Date:7/15/2009

p>

NovoLog((R)) is a rapid-acting insulin analog, meaning it works faster and for a shorter period of time compared with regular human insulin. NovoLog((R)) is also available in FlexPen((R)), the world's #1 selling prefilled insulin pen. Diabetes patients who take NovoLog((R)) can eat within 5-10 minutes of use, rather than the typical 30 minutes required with regular human insulin.

NovoLog((R)) was first approved by the FDA in 2000 and approved for use in pumps in 2001.

Prescribing information for NovoLog((R)) is available by contacting Novo Nordisk or visiting http://www.novolog.com.

About NovoLog (R) (insulin aspart [rDNA origin] injection)

NovoLog (R) is a man-made insulin that is used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information

Do not take NovoLog(R) if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in NovoLog(R). If you take too much NovoLog(R) your blood sugar may fall too low.

NovoLog(R) is a fast-acting insulin. You should eat a meal within 5 to 10 minutes after using NovoLog(R) to avoid low blood sugar. Do not inject NovoLog(R) if you do not plan to eat right after using NovoLog(R). Check your blood sugar levels. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take NovoLog(R).

Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin.

Do not mix NovoLog(R) with any other insulins when used in a pump or with any insulins other than NPH when used with injecti
'/>"/>

SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Fitness Management Group, Inc. Approves Sale of the Company
2. Cardinal Health Board of Directors Approves CareFusion Spinoff
3. Video: FDA Approves Hologics Adiana(R) Permanent Contraception System
4. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
5. FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
6. FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
7. FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing
8. FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
9. ClearWay Minnesota(SM) Board Approves Four Regional Grants
10. Department of Defense Approves ISSA as Fitness Education Provider to Military Spouses
11. FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... ... Having access to a doctor can sometimes be a challenge for a variety of ... which affects hospitals’ abilities to provide quality service to those with serious needs, increases ... problem has recently presented itself, the new telemedicine platform and app, DocChat . ...
(Date:9/4/2015)... ... , ... Lalonde Gordon ran a 44.64 seconds scorcher in the third and ... 400 meters final, with an impressive 44.89 seconds at the 2015 North American, Central ... in August 2015. The 44.64 time is a new NACAC Championship record. , ...
(Date:9/4/2015)... Washington, DC (PRWEB) , ... September 04, 2015 ... ... dollar-wise they all pale in comparison to settlements under the Stark physician self-referral ... an upcoming Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... a Labor Day offer that cannot be passed up. FiltersFast.com, will ship ... necessary air and water filtration product replacements. Take advantage of this promotion now ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Friday night, Chicago ... hosting Generation Rescue’s A Night of Hope event supporting families affected by autism, raising ... Rowena and Joe Salas, joined together at the Oscar Swan Inn to support the ...
Breaking Medicine News(10 mins):Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... , , , ... were considered prized possessions of the Emperors of China and were personally ... Monarchs of Europe and discerning people all over the world. This luxurious ... most popular dog breeds today. , , ...
... , KUALA LUMPUR, Malaysia, Aug. 26 ... privatization within the healthcare service provision and upgrading of existing ... services has also received positive impetus from growing promotion of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , According ...
... Health Group Inc. ("AIM" or the "Company") (TSXV - AHG), ... net income for the three month period ended June 30, ... $118,223 in the same period in 2008. At the same ... quarter-over-quarter basis. The Company also announced that revenues increased 102% ...
... is the GlaxoSmithKline statement in response to the FDA,s Early Communication about ... stands firmly behind the safety and efficacy of alli . ... that there is no evidence that alli causes liver damage. ... cases on liver injury associated with the use of orlistat/alli. Any routine ...
... restart production of missing protein , TUESDAY, Aug. 25 ... appears to jump-start the production of a crucial protein ... researchers report. , The treatment so far is only ... debilitating and ultimately fatal disease, but scientists are hopeful ...
... with coronary artery disease-induced congestive heart failure or heart ... radiation therapy for treatment of prostate cancer have an ... in the August 26 issue of JAMA . ... options available for treatment, including the use of brachytherapy ...
Cached Medicine News:Health News:Royal Canin Continues to Pioneer the Pet Food Industry With an Exclusive Diet Just for Pugs 2Health News:Frost & Sullivan: Growing Healthcare Tourism in Malaysia 2Health News:Frost & Sullivan: Growing Healthcare Tourism in Malaysia 3Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 2Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 3Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 4Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 5Health News:Experimental Treatment Could Fight Muscular Dystrophy 2Health News:Hormone therapy for prostate cancer patients with heart conditions linked to increased death risk 2
(Date:9/4/2015)... , September 4, 2015 ... by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by ... and by Product - Global Forecast to 2020", published ... reach USD 2.5 Billion by 2020, growing at a ... to 2020. Browse 139 Tables and ...
(Date:9/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... & Renshaw 17 th Annual Global Investment Conference, ... York City .  Dr. Michael Berelowitz , ... September 9, 2015. Presentation Details: ...
(Date:9/4/2015)... N.J. , Sept. 4, 2015  IGI Laboratories, ... based specialty generic pharmaceutical company, today announced ... (ANDA) to the U.S. Food and Drug Administration (FDA) ... ANDA submissions now pending at the FDA to twenty-nine. ... of the Company, commented, "We believe our current pipeline ...
Breaking Medicine Technology:Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2
... A Denver ophthalmologist recently became the first in Colorado ... raising the bar for patient care in the state while ... Paul Cutarelli, director of Cutarelli Vision in Denver and Fort ... in the eye of a 70-year-old man whose cataracts in ...
... (NYSE: IMA ), a global leader in enabling individuals to ... rapid diagnostics and health management, today announced its financial results for ... for the third quarter of 2009: , Net ... to $438.8 million for the third quarter of 2008. GAAP ...
Cached Medicine Technology:Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 2Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 3Inverness Medical Innovations Announces Third Quarter 2009 Results 2Inverness Medical Innovations Announces Third Quarter 2009 Results 3Inverness Medical Innovations Announces Third Quarter 2009 Results 4Inverness Medical Innovations Announces Third Quarter 2009 Results 5Inverness Medical Innovations Announces Third Quarter 2009 Results 6Inverness Medical Innovations Announces Third Quarter 2009 Results 7Inverness Medical Innovations Announces Third Quarter 2009 Results 8Inverness Medical Innovations Announces Third Quarter 2009 Results 9Inverness Medical Innovations Announces Third Quarter 2009 Results 10Inverness Medical Innovations Announces Third Quarter 2009 Results 11Inverness Medical Innovations Announces Third Quarter 2009 Results 12Inverness Medical Innovations Announces Third Quarter 2009 Results 13Inverness Medical Innovations Announces Third Quarter 2009 Results 14Inverness Medical Innovations Announces Third Quarter 2009 Results 15Inverness Medical Innovations Announces Third Quarter 2009 Results 16Inverness Medical Innovations Announces Third Quarter 2009 Results 17
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: